Ignite Creation Date:
2024-05-05 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00464282
Status:
COMPLETED
Last Update Posted:
2007-04-23
First Post:
2007-04-20
Brief Title:
Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer
Sponsor:
Gunma University
Organization:
Gunma University
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2007-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Objective L-3-18F-α-methyltyrosine FMT is an amino-acid tracer for PET We evaluated the diagnostic usefulness of 18F-FMT PET in non-small cell lung cancer NSCLC patients Tumor uptake of 18F-FMT PET was compared with 18F-FDG PET and the correlation with L-type amino acid transporter 1 LAT1 expression also investigated
Method Fifty patients with NSCLC were enrolled in this study and a pair of PET study with 18F-FMT and 18F-FDG was performed LAT1 expression and Ki-67 labeling index of the resected tumors were analyzed by immunohistochemical study
Method Fifty patients with NSCLC were enrolled in this study and a pair of PET study with 18F-FMT and 18F-FDG was performed LAT1 expression and Ki-67 labeling index of the resected tumors were analyzed by immunohistochemical study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None